CRSP vs CYTK
CRISPR Therapeutics AG · Cytokinetics, Incorporated
Relative return (rebased to 100)
Key stats
| Metric | CRSP | CYTK |
|---|---|---|
| Price | $55.79 | $72.72 |
| Market Cap | $5.39B | $10.11B |
| P/E | — | — |
| P/B | 3.09 | — |
| P/S | 1536.89 | 114.83 |
| ROE | -33.3% | — |
| Net Margin | -16569.8% | -891.6% |
| Gross Margin | — | — |
| Revenue Growth | -90.6% | 376.6% |
| Dividend Yield | — | — |
| EPS | -$6.01 | -$5.65 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.